Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Cosette Wheeler
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Disorders
Chemicals & Drugs
Procedures
Concepts & Ideas
Anatomy
Geographic Areas
Sign-in to see full Profile
Network (preview)
25
Schiffman, Mark
18
Castle, Philip
15
Koutsky, Laura
15
Becker, Thomas
13
Peyton, Cheri
12
Solomon, Diane
12
Gravitt, Patti
10
Barr, Eliav
10
Hildesheim, Allan
8
Hunt, William
7
Jansen, Kathrin
7
Kiviat, Nancy
7
Manos, Michele
7
Harper, Diane
7
Apple, Raymond
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Cosette Wheeler (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Franceschi Silvia; Cuzick Jack; Herrero Rolando; Dillner Joakim; Wheeler Cosette M
EUROGIN 2008 roadmap on cervical cancer prevention.
International journal of cancer. Journal international du cancer 2009;125(10):2246-55.
-
2009: Massad L Stewart; Einstein Mark; Myers Evan; Wheeler Cosette M; Wentzensen Nicolas; Solomon Diane
The impact of human papillomavirus vaccination on cervical cancer prevention efforts.
Gynecologic oncology 2009;114(2):360-4.
-
2009: Paavonen J; Naud P; Salmerón J; Wheeler C M; Chow S-N; Apter D; Kitchener H; Castellsague X; Teixeira J C; Skinner S R; Hedrick J; Jaisamrarn U; Limson G; Garland S; Szarewski A; Romanowski B; Aoki F Y; Schwarz T F; Poppe W A J; Bosch F X; Jenkins D; Hardt K; Zahaf T; Descamps D; Struyf F; Lehtinen M; Dubin G; Greenacre Mary
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.
Lancet 2009;374(9686):301-14.
-
2009: Castle Philip E; Kreimer Aimée R; Wacholder Sholom; Wheeler Cosette M; Koutsky Laura A; Rydzak Greg; Buckman Dennis W; Graubard Barry; Schiffman Mark
Influence of loop electrosurgical excision procedure on subsequent acquisition of new human papillomavirus infections.
The Journal of infectious diseases 2009;199(11):1612-20.
-
2009: Wentzensen Nicolas; Gravitt Patti E; Solomon Diane; Wheeler Cosette M; Castle Philip E
A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(5):1341-9.
-
2009: Safaeian Mahboobeh; Schiffman Mark; Gage Julia; Solomon Diane; Wheeler Cosette M; Castle Philip E
Detection of precancerous cervical lesions is differential by human papillomavirus type.
Cancer research 2009;69(8):3262-6.
-
2009: Wheeler Cosette M; Hunt William C; Joste Nancy E; Key Charles R; Quint Wim G V; Castle Philip E
Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.
Journal of the National Cancer Institute 2009;101(7):475-87.
-
2009: Xi Long Fu; Koutsky Laura A; Castle Philip E; Wheeler Cosette M; Galloway Denise A; Mao Constance; Ho Jesse; Kiviat Nancy B
Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3.
Journal of the National Cancer Institute 2009;101(3):153-61.
-
2009: Castle Philip E; Schiffman Mark; Wheeler Cosette M; Solomon Diane
Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2.
Obstetrics and gynecology 2009;113(1):18-25.
-
2008: Wheeler Cosette Marie
Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer.
Obstetrics and gynecology clinics of North America 2008;35(4):519-36; vii.
-
2008: Castle Philip E; Cox J Thomas; Schiffman Mark; Wheeler Cosette M; Solomon Diane
Factors influencing histologic confirmation of high-grade squamous intraepithelial lesion cytology.
Obstetrics and gynecology 2008;112(3):637-45.
-
2008: Gravitt Patti E; Coutlée François; Iftner Thomas; Sellors John W; Quint Wim G V; Wheeler Cosette M
New technologies in cervical cancer screening.
Vaccine 2008;26 Suppl 10():K42-52.
-
2008: Castle Philip E; Solomon Diane; Wheeler Cosette M; Gravitt Patti E; Wacholder Sholom; Schiffman Mark
Human papillomavirus genotype specificity of hybrid capture 2.
Journal of clinical microbiology 2008;46(8):2595-604.
-
2008: Gravitt Patti E; Schiffman Mark; Solomon Diane; Wheeler Cosette M; Castle Philip E
A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(5):1248-54.
-
2008: Castle Philip E; Cox J Thomas; Jeronimo Jose; Solomon Diane; Wheeler Cosette M; Gravitt Patti E; Schiffman Mark
An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS).
Obstetrics and gynecology 2008;111(4):847-56.
-
2008: Wheeler Cosette M; Franceschi Silvia
EUROGIN 2007 roadmap--conclusion.
Vaccine 2008;26 Suppl 1():A28-31.
-
2008: Deshpande Alina; Wheeler Cosette M; Hunt William C; Peyton Cheri L; White P Scott; Valdez Yolanda E; Nolan John P
Variation in HLA class I antigen-processing genes and susceptibility to human papillomavirus type 16-associated cervical cancer.
The Journal of infectious diseases 2008;197(3):371-81.
-
2008: Wheeler Cosette M; Bautista Oliver M; Tomassini Joanne E; Nelson Margaret; Sattler Carlos A; Barr Eliav;
Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines.
Vaccine 2008;26(5):686-96.
-
2008: Castle Philip E; Gravitt Patti E; Solomon Diane; Wheeler Cosette M; Schiffman Mark
Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study.
Journal of clinical microbiology 2008;46(1):109-17.
-
2007: Paavonen Jorma; Jenkins David; Bosch F Xavier; Naud Paulo; Salmerón Jorge; Wheeler Cosette M; Chow Song-Nan; Apter Dan L; Kitchener Henry C; Castellsague Xavier; de Carvalho Newton S; Skinner S Rachel; Harper Diane M; Hedrick James A; Jaisamrarn Unnop; Limson Genara A M; Dionne Marc; Quint Wim; Spiessens Bart; Peeters Pascal; Struyf Frank; Wieting Susan L; Lehtinen Matti O; Dubin Gary;
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.
Lancet 2007;369(9580):2161-70.
-
2007: Plummer Martyn; Schiffman Mark; Castle Philip E; Maucort-Boulch Delphine; Wheeler Cosette M;
A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion.
The Journal of infectious diseases 2007;195(11):1582-9.
-
2007: Garland Suzanne M; Steben Marc; Hernandez-Avila Mauricio; Koutsky Laura A; Wheeler Cosette M; Perez Gonzalo; Harper Diane M; Leodolter Sepp; Tang Grace W K; Ferris Daron G; Esser Mark T; Vuocolo Scott C; Nelson Micki; Railkar Radha; Sattler Carlos; Barr Eliav;
Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccines.
Clinical and vaccine immunology : CVI 2007;14(6):792-5.
-
2007: Joura Elmar A; Leodolter Sepp; Hernandez-Avila Mauricio; Wheeler Cosette M; Perez Gonzalo; Koutsky Laura A; Garland Suzanne M; Harper Diane M; Tang Grace W K; Ferris Daron G; Steben Marc; Jones Ronald W; Bryan Janine; Taddeo Frank J; Bautista Oliver M; Esser Mark T; Sings Heather L; Nelson Micki; Boslego John W; Sattler Carlos; Barr Eliav; Paavonen Jorma
Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials.
Lancet 2007;369(9574):1693-702.
-
2007: Garland Suzanne M; Hernandez-Avila Mauricio; Wheeler Cosette M; Perez Gonzalo; Harper Diane M; Leodolter Sepp; Tang Grace W K; Ferris Daron G; Steben Marc; Bryan Janine; Taddeo Frank J; Railkar Radha; Esser Mark T; Sings Heather L; Nelson Micki; Boslego John; Sattler Carlos; Barr Eliav; Koutsky Laura A;
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.
The New England journal of medicine 2007;356(19):1928-43.
-
2007: Xi Long Fu; Kiviat Nancy B; Wheeler Cosette M; Kreimer Aimee; Ho Jesse; Koutsky Laura A
Risk of cervical intraepithelial neoplasia grade 2 or 3 after loop electrosurgical excision procedure associated with human papillomavirus type 16 variants.
The Journal of infectious diseases 2007;195(9):1340-4.
-
2007: Wheeler Cosette M
Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing.
Nature clinical practice. Oncology 2007;4(4):224-35.
-
2007: Saslow Debbie; Castle Philip E; Cox J Thomas; Davey Diane D; Einstein Mark H; Ferris Daron G; Goldie Sue J; Harper Diane M; Kinney Walter; Moscicki Anna-Barbara; Noller Kenneth L; Wheeler Cosette M; Ades Terri; Andrews Kimberly S; Doroshenk Mary K; Kahn Kelly Green; Schmidt Christy; Shafey Omar; Smith Robert A; Partridge Edward E; Garcia Francisco
American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors.
CA: a cancer journal for clinicians 2007;57(1):7-28.
-
2007: Kreimer Aimée R; Katki Hormuzd A; Schiffman Mark; Wheeler Cosette M; Castle Philip E;
Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(1):11-6.
-
2007: Xi Long Fu; Koutsky Laura A; Hildesheim Allan; Galloway Denise A; Wheeler Cosette M; Winer Rachel L; Ho Jesse; Kiviat Nancy B
Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(1):4-10.
-
2007: Saslow Debbie; Wheeler Cosette M
Human papillomavirus vaccines: who will pay, who will receive, when to administer?
Ethnicity & disease 2007;17(2 Suppl 2):S2-8-13.
-
2006: Wheeler Cosette M; Hunt William C; Schiffman Mark; Castle Philip E;
Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer.
The Journal of infectious diseases 2006;194(9):1291-9.
-
2006: Pagliusi Sonia R; Dillner Joakim; Pawlita Michael; Quint Wim G V; Wheeler Cosette M; Ferguson M
Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays--an update.
Vaccine 2006;24 Suppl 3():S3/193-200.
-
2006: Xi Long Fu; Kiviat Nancy B; Hildesheim Allan; Galloway Denise A; Wheeler Cosette M; Ho Jesse; Koutsky Laura A
Human papillomavirus type 16 and 18 variants: race-related distribution and persistence.
Journal of the National Cancer Institute 2006;98(15):1045-52.
-
2006: Kreimer Aimée R; Guido Richard S; Solomon Diane; Schiffman Mark; Wacholder Sholom; Jeronimo José; Wheeler Cosette M; Castle Philip E
Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(5):908-14.
-
2006: Arias-Pulido Hugo; Peyton Cheri L; Joste Nancy E; Vargas Hernan; Wheeler Cosette M
Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer.
Journal of clinical microbiology 2006;44(5):1755-62.
-
2006: Harper Diane M; Franco Eduardo L; Wheeler Cosette M; Moscicki Anna-Barbara; Romanowski Barbara; Roteli-Martins Cecilia M; Jenkins David; Schuind Anne; Costa Clemens Sue Ann; Dubin Gary;
Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial.
Lancet 2006;367(9518):1247-55.
-
2006: Quint Wim G V; Pagliusi Sonia R; Lelie Nico; de Villiers Ethel-Michele; Wheeler Cosette M;
Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA.
Journal of clinical microbiology 2006;44(2):571-9.
-
2006: Mao Constance; Koutsky Laura A; Ault Kevin A; Wheeler Cosette M; Brown Darron R; Wiley Dorothy J; Alvarez Frances B; Bautista Oliver M; Jansen Kathrin U; Barr Eliav
Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial.
Obstetrics and gynecology 2006;107(1):18-27.
-
2005: Castle Philip E; Walker Joan L; Schiffman Mark; Wheeler Cosette M
Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology.
International journal of cancer. Journal international du cancer 2005;117(6):1007-12.
-
2005: Schiffman Mark; Wheeler Cosette M; Dasgupta Abhijit; Solomon Diane; Castle Philip E;
A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal papanicolaou smears.
American journal of clinical pathology 2005;124(5):722-32.
-
2005: Schiff Melissa A; Apple Raymond J; Lin Patricia; Nelson J Lee; Wheeler Cosette M; Becker Thomas M
HLA alleles and risk of cervical intraepithelial neoplasia among southwestern American Indian women.
Human immunology 2005;66(10):1050-6.
-
2005: Castle Philip E; Solomon Diane; Schiffman Mark; Wheeler Cosette M
Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.
Journal of the National Cancer Institute 2005;97(14):1066-71.
-
2005: Arias-Pulido Hugo; Peyton Cheri L; Torrez-Martínez Norah; Anderson D Nelson; Wheeler Cosette M
Human papillomavirus type 18 variant lineages in United States populations characterized by sequence analysis of LCR-E6, E2, and L1 regions.
Virology 2005;338(1):22-34.
-
2005: Yang Rongcun; Wheeler Cosette M; Chen Xiaojiang; Uematsu Satoshi; Takeda Kiyoshi; Akira Shizuo; Pastrana Diana V; Viscidi Raphael P; Roden Richard B S
Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
Journal of virology 2005;79(11):6741-50.
-
2005: McIntyre-Seltman Kathleen; Castle Philip E; Guido Richard; Schiffman Mark; Wheeler Cosette M;
Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(5):1165-70.
-
2005: Villa Luisa L; Costa Ronaldo L R; Petta Carlos A; Andrade Rosires P; Ault Kevin A; Giuliano Anna R; Wheeler Cosette M; Koutsky Laura A; Malm Christian; Lehtinen Matti; Skjeldestad Finn Egil; Olsson Sven-Eric; Steinwall Margareta; Brown Darron R; Kurman Robert J; Ronnett Brigitte M; Stoler Mark H; Ferenczy Alex; Harper Diane M; Tamms Gretchen M; Yu Jimmy; Lupinacci Lisa; Railkar Radha; Taddeo Frank J; Jansen Kathrin U; Esser Mark T; Sings Heather L; Saah Alfred J; Barr Eliav
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.
The lancet oncology 2005;6(5):271-8.
-
2005: Deshpande Alina; Nolan John P; White P Scott; Valdez Yolanda E; Hunt William C; Peyton Cheri L; Wheeler Cosette M
TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer.
The Journal of infectious diseases 2005;191(6):969-76.
-
2005: Schiffman Mark; Khan Michelle J; Solomon Diane; Herrero Rolando; Wacholder Sholom; Hildesheim Allan; Rodriguez Ana Cecilia; Bratti Maria C; Wheeler Cosette M; Burk Robert D;
A study of the impact of adding HPV types to cervical cancer screening and triage tests.
Journal of the National Cancer Institute 2005;97(2):147-50.
-
2004: Castle Philip E; Schiffman Mark; Wheeler Cosette M
Hybrid capture 2 viral load and the 2-year cumulative risk of cervical intraepithelial neoplasia grade 3 or cancer.
American journal of obstetrics and gynecology 2004;191(5):1590-7.
-
2004: Castle Philip E; Wheeler Cosette M; Solomon Diane; Schiffman Mark; Peyton Cheri L;
Interlaboratory reliability of Hybrid Capture 2.
American journal of clinical pathology 2004;122(2):238-45.
-
2004: Arias-Pulido Hugo; Joste Nancy; Wheeler Cosette M
Loss of heterozygosity on chromosome 6 in HPV-16 positive cervical carcinomas carrying the DRB1*1501-DQB1*0602 haplotype.
Genes, chromosomes & cancer 2004;40(4):277-84.
-
2004: Fife Kenneth H; Wheeler Cosette M; Koutsky Laura A; Barr Eliav; Brown Darron R; Schiff Melissa A; Kiviat Nancy B; Jansen Kathrin U; Barber Harriet; Smith Judith F; Tadesse Amha; Giacoletti Katherine; Smith Paula R; Suhr Gretchen; Johnson Daniel A
Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy women.
Vaccine 2004;22(21-22):2943-52.
-
2004: Brown Darron R; Fife Kenneth H; Wheeler Cosette M; Koutsky Laura A; Lupinacci Lisa M; Railkar Radha; Suhr Gretchen; Barr Eliav; Dicello Anthony; Li Weili; Smith Judith F; Tadesse Amha; Jansen Kathrin U
Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine.
Vaccine 2004;22(21-22):2936-42.
-
2003: Sherman Mark E; Wang Sophia S; Wheeler Cosette M; Rich Laurie; Gravitt Patti E; Tarone Robert; Schiffman Mark
Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: dominant impact of surrounding low-grade lesions.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(10):1038-44.
-
2003: Badal Vinay; Chuang Linda S H; Tan Eileen Hwee-Hong; Badal Sushma; Villa Luisa L; Wheeler Cosette M; Li Benjamin F L; Bernard Hans-Ulrich
CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression.
Journal of virology 2003;77(11):6227-34.
-
2003: Tran-Thanh Danh; Provencher Diane; Koushik Anita; Duarte-Franco Eliane; Kessous Allégria; Drouin Pierre; Wheeler Cosette M; Dubuc-Lissoir Josée; Gauthier Philippe; Allaire Guy; Vauclair René; Dipaolo Joseph A; Gravitt Patty; Franco Eduardo; Coutlée Francois
Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervix.
American journal of obstetrics and gynecology 2003;188(1):129-34.
-
2002: Koutsky Laura A; Ault Kevin A; Wheeler Cosette M; Brown Darron R; Barr Eliav; Alvarez Frances B; Chiacchierini Lisa M; Jansen Kathrin U;
A controlled trial of a human papillomavirus type 16 vaccine.
The New England journal of medicine 2002;347(21):1645-51.
-
2002: Schiffman Mark; Wheeler Cosette M; Castle Philip E;
Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities.
The Journal of infectious diseases 2002;186(8):1169-72.
-
2002: Emeny Rebecca T; Wheeler Cosette M; Jansen Kathrin U; Hunt William C; Fu Tong-Ming; Smith Judith F; MacMullen Stefani; Esser Mark T; Paliard Xavier
Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine.
Journal of virology 2002;76(15):7832-42.
-
2002: van Doorn Leen-Jan; Quint Wim; Kleter Bernhard; Molijn Anco; Colau Brigitte; Martin Marie-Thérèse; Kravang-In; Torrez-Martinez Norah; Peyton Cheri L; Wheeler Cosette M
Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay.
Journal of clinical microbiology 2002;40(3):979-83.
-
2001: Schiff M A; Patterson R E; Baumgartner R N; Masuk M; van Asselt-King L; Wheeler C M; Becker T M
Serum carotenoids and risk of cervical intraepithelial neoplasia in Southwestern American Indian women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(11):1219-22.
-
2001: Wang S S; Wheeler C M; Hildesheim A; Schiffman M; Herrero R; Bratti M C; Sherman M E; Alfaro M; Hutchinson M L; Morales J; Lorincz A; Burk R D; Carrington M; Erlich H A; Apple R J
Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica.
The Journal of infectious diseases 2001;184(10):1310-4.
-
2001: Brown D R; Bryan J T; Schroeder J M; Robinson T S; Fife K H; Wheeler C M; Barr E; Smith P R; Chiacchierini L; DiCello A; Jansen K U
Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: correlation with competitive radioimmunoassay titer.
The Journal of infectious diseases 2001;184(9):1183-6.
-
2001: Peyton C L; Gravitt P E; Hunt W C; Hundley R S; Zhao M; Apple R J; Wheeler C M
Determinants of genital human papillomavirus detection in a US population.
The Journal of infectious diseases 2001;183(11):1554-64.
-
2000: Schiff M; Miller J; Masuk M; van Asselt King L; Altobelli K K; Wheeler C M; Becker T M
Contraceptive and reproductive risk factors for cervical intraepithelial neoplasia in American Indian women.
International journal of epidemiology 2000;29(6):983-90.
-
2000: Schiff M; Becker T M; Masuk M; van Asselt-King L; Wheeler C M; Altobelli K K; North C Q; Nahmias A J
Risk factors for cervical intraepithelial neoplasia in southwestern American Indian women.
American journal of epidemiology 2000;152(8):716-26.
-
2000: Kämmer C; Warthorst U; Torrez-Martinez N; Wheeler C M; Pfister H
Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity.
The Journal of general virology 2000;81(Pt 8):1975-81.
-
2000: Gravitt P E; Peyton C L; Alessi T Q; Wheeler C M; Coutlée F; Hildesheim A; Schiffman M H; Scott D R; Apple R J
Improved amplification of genital human papillomaviruses.
Journal of clinical microbiology 2000;38(1):357-61.
-
1999: Emeny R T; Herron J R; Xi L F; Koutsky L A; Kiviat N B; Wheeler C M
Comparison of variant-specific hybridization and single-strand conformational polymorphism methods for detection of mixed human papillomavirus type 16 variant infections.
Journal of clinical microbiology 1999;37(11):3627-33.
-
1999: Eriksson A; Herron J R; Yamada T; Wheeler C M
Human papillomavirus type 16 variant lineages characterized by nucleotide sequence analysis of the E5 coding segment and the E2 hinge region.
The Journal of general virology 1999;80 ( Pt 3)():595-600.
-
1999: Hildesheim A; Hadjimichael O; Schwartz P E; Wheeler C M; Barnes W; Lowell D M; Willett J; Schiffman M
Risk factors for rapid-onset cervical cancer.
American journal of obstetrics and gynecology 1999;180(3 Pt 1):571-7.
-
1998: Peyton C L; Schiffman M; Lörincz A T; Hunt W C; Mielzynska I; Bratti C; Eaton S; Hildesheim A; Morera L A; Rodriguez A C; Herrero R; Sherman M E; Wheeler C M
Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies.
Journal of clinical microbiology 1998;36(11):3248-54.
-
1998: Gravitt P E; Peyton C L; Apple R J; Wheeler C M
Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method.
Journal of clinical microbiology 1998;36(10):3020-7.
-
1998: Xi L F; Critchlow C W; Wheeler C M; Koutsky L A; Galloway D A; Kuypers J; Hughes J P; Hawes S E; Surawicz C; Goldbaum G; Holmes K K; Kiviat N B
Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants.
Cancer research 1998;58(17):3839-44.
-
1997: Wheeler C M
Preventive vaccines for cervical cancer.
Salud pública de México 1997;39(4):283-7.
-
1997: Xi L F; Koutsky L A; Galloway D A; Kuypers J; Hughes J P; Wheeler C M; Holmes K K; Kiviat N B
Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia.
Journal of the National Cancer Institute 1997;89(11):796-802.
-
1997: Yamada T; Manos M M; Peto J; Greer C E; Munoz N; Bosch F X; Wheeler C M
Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective.
Journal of virology 1997;71(3):2463-72.
-
1997: Wheeler C M; Yamada T; Hildesheim A; Jenison S A
Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization.
Journal of clinical microbiology 1997;35(1):11-9.
-
1996: Wheeler C M; Greer C E; Becker T M; Hunt W C; Anderson S M; Manos M M
Short-term fluctuations in the detection of cervical human papillomavirus DNA.
Obstetrics and gynecology 1996;88(2):261-8.
-
1996: Stewart A C; Eriksson A M; Manos M M; Muñoz N; Bosch F X; Peto J; Wheeler C M
Intratype variation in 12 human papillomavirus types: a worldwide perspective.
Journal of virology 1996;70(5):3127-36.
-
1995: Yamada T; Wheeler C M; Halpern A L; Stewart A C; Hildesheim A; Jenison S A
Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments.
Journal of virology 1995;69(12):7743-53.
-
1995: Stewart A C; Gravitt P E; Cheng S; Wheeler C M
Generation of entire human papillomavirus genomes by long PCR: frequency of errors produced during amplification.
Genome research 1995;5(1):79-88.
-
1995: Greer C E; Wheeler C M; Ladner M B; Beutner K; Coyne M Y; Liang H; Langenberg A; Yen T S; Ralston R
Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts.
Journal of clinical microbiology 1995;33(8):2058-63.
-
1995: Apple R J; Becker T M; Wheeler C M; Erlich H A
Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma.
Journal of the National Cancer Institute 1995;87(6):427-36.
-
1994: Manos M M; Waldman J; Zhang T Y; Greer C E; Eichinger G; Schiffman M H; Wheeler C M
Epidemiology and partial nucleotide sequence of four novel genital human papillomaviruses.
The Journal of infectious diseases 1994;170(5):1096-9.
-
1994: Peyton C L; Jansen A M; Wheeler C M; Stewart A C; Peto J; Bosch F X; Muñoz N; Teyssie A R; Torroella M; Wabinga H R
A novel human papillomavirus sequence from an international cervical cancer study.
The Journal of infectious diseases 1994;170(5):1093-5.
-
1994: Peyton C L; Wheeler C M
Identification of five novel human papillomavirus sequences in the New Mexico triethnic population.
The Journal of infectious diseases 1994;170(5):1089-92.
-
1994: Bernard H U; Chan S Y; Manos M M; Ong C K; Villa L L; Delius H; Peyton C L; Bauer H M; Wheeler C M
Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms.
The Journal of infectious diseases 1994;170(5):1077-85.
-
1994: Becker T M; Wheeler C M; McGough N S; Stidley C A; Parmenter C A; Dorin M H; Jordan S W
Contraceptive and reproductive risks for cervical dysplasia in southwestern Hispanic and non-Hispanic white women.
International journal of epidemiology 1994;23(5):913-22.
-
1994: Greer C E; Wheeler C M; Manos M M
Sample preparation and PCR amplification from paraffin-embedded tissues.
PCR methods and applications 1994;3(6):S113-22.
-
1994: Becker T M; Wheeler C M; McGough N S; Parmenter C A; Jordan S W; Stidley C A; McPherson R S; Dorin M H
Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women.
JAMA : the journal of the American Medical Association 1994;271(15):1181-8.
-
1994: Kirnbauer R; Hubbert N L; Wheeler C M; Becker T M; Lowy D R; Schiller J T
A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.
Journal of the National Cancer Institute 1994;86(7):494-9.
-
1994: Becker T M; Wheeler C M; McGough N S; Parmenter C A; Stidley C A; Jamison S F; Jordan S W
Cigarette smoking and other risk factors for cervical dysplasia in southwestern Hispanic and non-Hispanic white women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1994;3(2):113-9.
-
1994: Apple R J; Erlich H A; Klitz W; Manos M M; Becker T M; Wheeler C M
HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.
Nature genetics 1994;6(2):157-62.
-
1993: Becker T M; Wheeler C M; McPherson R S; Kratochvil A; Parmenter C A; North C Q; Miller J A
Risk factors for cervical dysplasia in southwestern American Indian women: a pilot study.
Alaska medicine 1993;35(4):255-63.
-
1993: Wheeler C M; Parmenter C A; Hunt W C; Becker T M; Greer C E; Hildesheim A; Manos M M
Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center.
Sexually transmitted diseases 1993;20(5):286-9.
-
1992: Becker T M; Wheeler C M; Key C R; Samet J M
Cervical cancer incidence and mortality in New Mexico's Hispanics, American Indians, and non-Hispanic whites.
The Western journal of medicine 1992;156(4):376-9.
-
1991: Becker T M; Wheeler C M; McGough N S; Jordan S W; Dorin M; Miller J
Cervical papillomavirus infection and cervical dysplasia in Hispanic, Native American, and non-Hispanic white women in New Mexico.
American journal of public health 1991;81(5):582-6.
Sign-in to see more